Taking people in ChinaNo phase
Intelligent Diagnosis and Treatment Model for Insomnia Disorder
Key facts
- Where
- Beijing, Changchun, Chengdu, and Suzhou, ChinaSee the 5 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06375447, who can take part
Where in China
- Beijing Tiantan Hospital,Capital Medical UniversityBeijing, ChinaContact: Yi Zhang, MD & PhDTaking people
- Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaContact: Hongxing Wang, MD & PhDTaking people
- The First Bethune Hospital of Jilin UniversityChangchun, ChinaContact: Zan Wang, MD & PhDNot yet recruiting
- West China Hospital,Sichuan UniversityChengdu, ChinaContact: Lan Zhang, MD & PhDTaking people
- The Second Affiliated Hospital of Soochow UniversitySuzhou, ChinaContact: Hua Hu, MD & PhDNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Xuanwu Hospital, Beijing
- Trial code
- NCT06375447
- Record updated
- 10 December 2024
- Original description
To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.Read full original descriptionShow less
Study on an Intelligent Model for the Diagnosis and Treatment of Insomnia Disorder
To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.
Inclusion: A complaint of insomnia; Age between 18 and 75; Able to fill out the scale on their own; Agree to sign the informed consent to participate in the study and cooperate in completing the follow-up visit.
Exclusion: 1.A current or history of comorbid Axis I psychiatric disorders.